Loading
Latest filing published 07 Aug 2026 for Telo Genomics Corp.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of John Price in Telo Genomics Corp. We count 6 filings; the first trade dates from 30 January 2026 and the latest from 30 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 7 August 2026 came the latest disclosure, an option exercise in Telo Genomics Corp. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations